Does DACOMITINIB Cause Neoplasm progression? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Neoplasm progression have been filed in association with DACOMITINIB (Vizimpro). This represents 11.4% of all adverse event reports for DACOMITINIB.
78
Reports of Neoplasm progression with DACOMITINIB
11.4%
of all DACOMITINIB reports
39
Deaths
14
Hospitalizations
How Dangerous Is Neoplasm progression From DACOMITINIB?
Of the 78 reports, 39 (50.0%) resulted in death, 14 (17.9%) required hospitalization, and 3 (3.8%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACOMITINIB. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does DACOMITINIB Cause?
Death (253)
Diarrhoea (114)
Rash (108)
Paronychia (55)
Blood pressure increased (47)
Off label use (35)
Pruritus (34)
Dyspnoea (30)
Carcinoembryonic antigen increased (28)
Pain (28)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which DACOMITINIB Alternatives Have Lower Neoplasm progression Risk?
DACOMITINIB vs DACTINOMYCIN
DACOMITINIB vs DALBAVANCIN
DACOMITINIB vs DALFAMPRIDINE
DACOMITINIB vs DALTEPARIN
DACOMITINIB vs DAMOCTOCOG ALFA PEGOL